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In 2012, dengue ranks as the most important mosquito-borne disease in the world. Outbreaks exert a huge burden on populations, health systems, and economies [1]. In spite of the 
fact that in India, dengue was first reported in 1940s, the first case 
of confirmed dengue infection from Kerala was recorded in 1997 
only [2]. However, Kerala has become hyperendemic for dengue 
fever in the past two decades [3]. Disease incidence and deaths are 
the highest in children aged ≤15 years [4]. Dengue fever is classified 
according to the revised WHO classification as dengue without 
warning signs (D), dengue with warning signs (DWS), and severe 
dengue (SD) [5]. The clinical presentation and severity change over 
the years. There are very few studies describing the clinical profile 
of children with dengue fever in Kerala, especially with regard to 
severity as per the WHO classification 2012. The present study was 
conducted in children admitted with dengue fever in a tertiary care 
government medical college in Kerala from January 2013 to June 
2014 to look for the factors associated with SD.
MATERIALS AND METHODS
This was a descriptive study of children below 12 years of age 
admitted with the diagnosis of dengue fever in pediatric ward and 
intensive care unit. Children with pre-existing bleeding disorder, 
chronic liver disease, and proven viral hepatitis A or B were 
excluded from the study. All children satisfying the inclusion 
criteria were included in the study after getting prior written 
informed consent. They were thoroughly evaluated with detailed 
history and physical examination including nutritional status 
(assessed as per the Indian Academy of Pediatrics classification) 
such as complete blood count, packed cell volume, coagulation 
profile (prothrombin time [PT], international normalized ratio 
[INR], activated partial thromboplastin time [aPTT]), and liver 
and renal function tests. The dengue non-structural protein 1 
(NS1) antigen was done in children who presented in the 1st 5 days 
of illness. Dengue immunoglobulin (Ig) M and IgG were done 
after the 5th day of illness. Radiological evaluation such as X-ray 
chest, ultrasound abdomen, and computed tomography (CT) scan 
head was done wherever necessary.
Regular monitoring was done in all patients daily till 
discharge. The study population was classified as dengue fever 
without warning signs, dengue fever with warning signs (DWS), 
and SD according to the WHO guidelines 2012 (Fig. 1). They 
were also grouped into severe and non-SD to compare the 
baseline characteristics and coagulation abnormalities. In the 
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subset of cases where IgG was done, cases were classified as 
primary and secondary dengue based on IgG/Ig M ratio>1.1 [6]. 
The sample size was calculated as 300 based on a previous study 
using the formula 4pq/l2=284 (prevalence p=26%, q=100 –p=74, 
l=20% of  p) [7].
Results for continuous variables were expressed as means 
and standard deviation. Categorical variables were expressed as 
percentages. Student’s t-test for continuous variables and Chi-
square test for discrete variables were used to test significance. 
The p<0.05 was considered statistically significant. The SPSS 22 
software was used for statistical analysis.
RESULTS
A total of 306 children admitted with a diagnosis of dengue fever 
during the study period. Of 306 cases, majority 175 (57%) were in 
the age group of 6–12 years, 84 (27%) in the age group of 1–5 years, 
and 47 (16%) were infants. The mean age of the study population 
was estimated to be 7.8±3.2 years. Males were more in number 
(158) than females (148) with a male:female ratio of 1.06:1. A total 
of 216 (70.6%) children had normal nutritional status, 77 (25%) 
had Grade 1 malnutrition, and 13 (4.2%) had Grade 2 malnutrition.
Fever was present in all patients, with the duration of hospital 
stay <5 days in 205 (72%) and 5–10 days in 75 patients (25%). 
The most common symptoms were vomiting in 168 (54.90%), 
abdominal pain in 111 (36.3%), bleeding manifestation in 
43(14.05%), headache in 41(13.40%), myalgia in 32 (10.5%), 
and lethargy (9.8%). The other symptoms observed in our study 
were arthralgia (9.5%), altered sensorium (7.8%), rash (7.2%), 
diarrhea (6.5%), oliguria (6.5%), cough/rhinitis (5.2%), anorexia 
(3.9%), and retro-orbital pain (1.3%). Important clinical signs 
were hepatomegaly and narrow pulse pressure. Details of clinical 
signs are shown in Fig. 2. Of 306 cases, 14% had complications, 
the most common complication being shock (9.9%), followed by 
severe gastrointestinal bleeding (4.4%), acute respiratory distress 
syndrome (4%), acute kidney injury (4%), acute hepatic failure 
(3%), and myocarditis (1.6%). There were 3 cases of intracranial 
bleed and 2 cases of dengue encephalitis in our study. Of the two 
cases of dengue encephalitis, we obtained IgG dengue positivity 
from CSF in one child whose CT brain showed hypodensities in 
bilateral thalami and cerebellar region (Fig. 3). The child presented 
with gaze palsy and extrapyramidal movements. MRI brain of the 
other child showed acute hemorrhagic leukoencephalitis. Both 
the children recovered completely.
Based on the clinical symptoms and signs, 131 (42.8%) were 
classified as dengue fever without warning signs, 119 (38.8%) as 
DWS, and 56 (18.4%) as SD, according to the WHO guidelines 
2012. NS1 antigen was done in only 168 patients and was 
positive in 76% of cases. IgM dengue positivity was 90.8%. The 
investigation was not done in 9 cases as they got discharged before 
5 days of onset of illness and was lost to follow-up. Even though 
19 cases had negative IgM dengue, they fall into probable dengue 
according to the WHO criteria. Among 252 cases in which IgG 
was done, positivity was seen in 131 (42%) cases.
The liver enzymes aspartate aminotransferase (AST) and 
alanine aminotransferase (ALT) were elevated significantly in 
SD compared to non-SD (Table 1). 102 (33.3%) children had 
prolonged aPTT, while 64 (20.9%) had elevated prothrombin 
Figure 1: Dengue case classification by sererity WHO 2012 (Ref.5). AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, 
CNS: Central nervous system, DSS: Dengue shock syndrome, HCT: Hematocrit
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time. The mean values of PT, INR, and aPTT in SD were 19±3.7 s, 
1.5±0.3 s, and 46±7 s, respectively. These are well above the 
cutoff values and show statistically significant association with 
SD. Of the total cases, 14.1% had a platelet count <20,000 and 
low platelet count was significantly correlated with the severity of 
dengue (Table 2). The mean platelet recovery time was 2–5 days.
The supportive measures used in the management of the 
study population included crystalloids (40.8%), colloids (11.4%), 
inotropes (8.8%), platelet transfusion (8.8%), packed red cells 
transfusion (8.8%), and fresh frozen plasma (7.5%). Mortality 
in the present study was 21 (7%). Among the cases who died 
of dengue fever, all had multi-organ dysfunction (100%) in the 
end. and the most common underlying predisposing conditions 
were acute respiratory distress syndrome (24%), refractory 
shock (24%), intracranial bleed (14%), massive gastrointestinal 
bleeding (14%), acute hepatic failure (14%), and myocarditis 
(10%). Of the total 306 cases, the subset in which IgG dengue 
was done (n=252) was classified as primary/secondary dengue 
based on IgM/IgG ratio. 193 cases (77%) were primary, and 
59 (23%) were secondary. There was no statistically significant 
difference in clinical severity between primary and secondary 
dengue (p=0.15).
DISCUSSION
Of the 306 cases of children admitted with dengue fever, 
131 (42.8%) were dengue fever without warning signs, 
119 (38.8%) were DWS, and 56 (18.4%) were SD according to 
the WHO guidelines 2012. Majority of the studies on dengue 
fever are based on previous the WHO classification as dengue 
fever, dengue hemorrhagic fever, and dengue shock syndrome. 
Only a few studies are there in the literature based on latest WHO 
guidelines [5]. In the study conducted by Sahana and Sujatha, of 
the total 81 children, only 39 (48.1%) had dengue fever without 
warning signs, 22 (27.2 %) had DWS, and 20 (24.7 %) patients 
had SD [8]. We observed that majority of the cases in our study 
belonged to the age group of 6–12 years (57%) and the proportion 
of infants was 16%. This was in accordance with other studies 
[8,9]. In the study conducted by Mittal et al., 68% cases were 
in the age group of 6–12 years, only 2.9% were infants and the 
mean age group was 8.3±3.5 years [9]. There was a slight male 
preponderance (male:female ratio - 1.06:1). Batra et al. reported 
a close figure of male:female ratio as our study (1.08:1) [10]. The 
covered clothing in a female may offer some protection from 
mosquito bite. However, Ratageri et al. noticed a male:female 
ratio of 0.92:1 [11]. The assessment of nutritional status of 
children in our study revealed that 70.6% had normal weight 
for age. Dengue fever did not occur in children beyond Grade II 
underweight in our study. Most of the cases of SD (69.9%) had 
normal weight. The literature also showed that dengue virus 
Figure 2: Bar chart demonstrating distribution of signs
Table 1: Liver enzymes and coagulation profile in subtypes of dengue fever
Parameters Reference value DNW (%) DWS (%) SD (%) p
PT >16 3 (2.30) 14 (11.80) 47 (83.90)
INR >1.1 29 (22) 71 (59.7) 54 (96.40)
aPTT >38 10 (7.60) 41 (34.50) 51 (91.10)
AST >400 6 (4.6) 10 (8.4) 33 (58.9) <0.001
ALT >400 2 (1.5) 4 (3.4) 46.4 (32) <0.001
AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, PT: Prothrombin time, aPTT: Activated partial thromboplastin time, INR: International normalized ratio, 
DNW: Dengue without warning sign, DWS: Dengue with warning sign, SD: Severe dengue
Figure 3: CT scan head showing bilateral thalamic hypodensity in a 
child with dengue encephalitis
Kumar et al. Clinical profile and outcome of dengue fever
Vol 5 | Issue 1 | Jan 2018 Indian J Child Health 35
infection is more severe among children with better nutritional 
status [12,13]. Children with good nutritional status can mount 
stronger immune response and have a higher risk of developing 
severe clinical manifestations.
The most common symptoms in dengue fever following 
fever were vomiting (54.9%) and abdominal pain (36.3%). The 
proportion of cases with vomiting and abdominal pain in the 
study conducted by Karoli et al. and Jhamb et al. were 63%, 58% 
and 61%, 51%, respectively [14,15]. The proportion of headache 
and bleeding manifestations was only 13.4% and 14.05%, 
respectively, while other studies showed higher incidence of the 
same. In the study by Mittal et al., the proportion of headache and 
bleeding manifestations was 63% and 48%, respectively [9]. Arti 
et al. reported 10% of altered sensorium almost similar to our 
study [16]. Ratageri et al. reported that 87% had hepatomegaly 
and 23% had signs of fluid retention [11]. Our study revealed 
icterus only in 1% of cases. Roy et al. reported an incidence of 
60% of icterus in their study while other studies reported lower 
incidence of jaundice similar to our study [17]. Lymphadenopathy 
was observed in a minor proportion of cases (1.3%). It was only 
reported in some studies describing the rare manifestation of 
hypoplastic left heart syndrome in dengue [18]. In our study, 
one of the two cases of dengue encephalitis, we obtained IgG 
dengue positivity from CSF. The same was not reported in the 
literature, though similar clinical observations were found in 
many studies [17,18].
Mortality in the present study was 7% (21 cases). Of the 
56 cases of SD, 37.5% succumbed. The case fatality rate of 
dengue among SD was 7.9% in the study conducted by Campos 
et al. Moraes et al. also reported a similar figure of 8.6% mortality 
in SD cases. Juneja et al. reported a mortality rate of 6.1% among 
SD cases [19-21]. Van Gorp et al. reported a mortality rate of 
26% among SD in their study [7]. This was the only study with a 
comparable mortality rate as our study. The mortality rate among 
SD was higher in our study, probably because, our hospital being 
a tertiary care center received cases of refractory complications 
from all the hyperendemic dengue areas in the vicinity and late 
referral from the periphery also added on. All the deaths in our 
study were due to multiorgan dysfunction.
In the study by Kassim et al., 32.2% of the samples were 
found positive for dengue NS1 antigen, 40.9% were IgM positive, 
and 36.1% were IgG positive for dengue virus [22]. Similarly, 
Sahana et al. study showed less number of IgM, IgG antibody, 
and 66.7% NS1 antigen positive. Our study showed higher yield 
for the serological markers compared to the previous study. When 
more number of cases are clinically diagnosed and subjected for 
antibody test, the percentage of positivity increases. The 19 cases 
who were IgM negative had all the clinical criteria for dengue 
as per the WHO guidelines 2012 and hence were included as 
probable dengue (dengue fever without warning signs).
The detailed analysis of coagulation markers in our study is 
given in Table 1. This observation was important as impaired 
fibrinolysis and coagulation are considered to be a potential 
pathogenic mechanism of SD [23]. Khalil et al. showed 
coagulopathy as a significant risk factor for mortality as well [24]. 
The study conducted by Van Gorp et al. and Isangkura et al. 
also showed similar results [7,25]. We observed that 90.8% had 
platelet count <100,000 and 14.1% had platelet count <20,000. Of 
the 56 cases of SD, 41.1% had a platelet count <20000 (Fig. 4). 
In the study by Mittal et al., 82% had thrombocytopenia and is 
comparable to our study [9].
The hepatic involvement of dengue in our study is evidenced 
by the elevation of hepatic transaminases. Statistical analysis 
Figure 4: Compound bar diagram showing distribution of platelet 
count in the subgroups of dengue fever
Table 2: Summary of baseline characteristics of severe and non‑SD
Characteristics Severe  
(n=56)
Non‑SD  
(n=250)
p**
Age (mean±SD) (years) 6.9±3.7 6.9±4.1
Male sex (%) 48.2 52.4
Vomiting (%) 68.9 52
Abdominal pain (%) 62.5 30.4
Bleeding 
manifestations (%)
53.6 6.8
Tender hepatomegaly (%) 75 26.4
Positive tourniquet test (%) 15 12.4
Laboratory 
parameters (mean±SD)
Hb 13±2.5 12±1.5 0.012
PCV 44±4 35±4 0.003
Platelet count 30980±2465 61820±7620 0.003
Bilirubin 0.7±0.3 0.5±0.2 <0.001
SGOT 1835±228 182±43 <0.001
SGPT 920±115 98±27 <0.001
Total protein 5±1.5 6.3±0.8 <0.001
Serum albumin 2.8±0.6 3.5±0.4 <0.001
Blood urea 35±2 19±0.7 <0.001
Serum creatinine 0.7±0.2 0.6±0.1 <0.001
Sodium 133±5 134±3 0.190
Potassium 4±0.6 4±0.5 0.019
Calcium 7.3±1.8 8.8±0.8 <0.001
Random blood sugar 65±6 85±4 <0.001
SGPT: Serum glutamic pyruvic transaminase, Hb: Hemoglobin, SGOT: Serum 
glutamate oxaloacetate transaminase, SD: Standard deviation, non‑SD: Non‑severe 
dengue, PCV: Packed cell volume, **: ???
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showed a significant difference in AST and ALT elevation among 
dengue fever without warning signs, DWS and SD (p<0.001). 
This was in accordance with other studies [9,17]. Of 306 cases, 
platelet recovery time was analyzed in 268 cases after excluding 
those who had platelet count >100,000 and those who did not 
survive. 85.1% had platelet recovery time between 2 and 5 days. 
Mittal et al. observed that mean platelet recovery time to be 
3.6±1.3 days and is comparable to our study. Among SD cases, 
also majority (64%) fell in between 2 and 5 days. In our study, 72% 
had a duration of hospitalization <5 days. This was in accordance 
with Mittal et al. in which mean duration of hospitalization was 
4.2±2.3 days [9].
We further classified the study population into two 
groups: Severe and non-SD. The latter comprises cases of 
DWS and dengue fever without warning signs (n=250). 
The baseline characteristics - demographic, clinical, and 
laboratory findings - of the two groups were compared 
(Table 2). It was observed that the mean age and gender 
distribution in both groups were almost similar. The incidence 
of vomiting, abdominal pain, bleeding manifestations, tender 
hepatomegaly, and positive tourniquet test was more in SD 
cases. Hemoconcentration, thrombocytopenia, hypoproteinemia, 
hypoalbuminemia hypocalcemia, hypoglycemia, hypokalemia, 
hepatic derangement, elevated urea, and creatinine were 
significantly associated with SD. The markers of coagulation 
were significantly prolonged in SD group (p<0.001). These 
findings were consistent with similar comparative study between 
survivors and non-survivors in a study by Von Gorp et al. [7]. 
Thus, the role of coagulation profile as a marker of severity in 
dengue is reinforced in our study.
On comparing the clinical severity in primary and secondary 
dengue, there was no significant difference among the proportion 
of the WHO subgroups of dengue cases. This was in contrast to 
the immune pathogenesis of SD through antibody enhancement 
in secondary dengue. Our study supported the hypothesis of 
severity inflicted by virulent strains of dengue [26]. The study by 
Hati revealed that, in the age group of 1–10 years, more primary 
dengue cases are seen while secondary dengue cases are more in 
the elderly [27]. This observation also stands in support to our 
finding that there is no relation of primary/secondary cases with 
respect to severity in children.
The liver enzymes, coagulation parameters, and the platelet 
count in dengue fever change during the course of the disease. 
However, we have analyzed the value at admission which might 
have affected the value of the study. This we feel, is one important 
limitation of the study
CONCLUSION
Dengue fever occurs more in older children with better nutritional 
status and has a male predilection. Tender hepatomegaly, vomiting, 
and abdominal pain are the most common signs and symptoms, 
and they tend to occur in increased frequency in SD. There is 
a statistically significant association between prolongation of 
coagulation markers and hepatic transaminase levels with severity 
of dengue. Testing for liver enzymes and markers of coagulation 
can act as predictors of severity in dengue fever. There was no 
statistically significant difference in severity between children 
with primary and secondary dengue fever.
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